key: cord-0806692-urpl38qw
authors: Henderson, Rory; Edwards, Robert J.; Mansouri, Katayoun; Janowska, Katarzyna; Stalls, Victoria; Gobeil, Sophie; Kopp, Megan; Li, Dapeng; Parks, Rob; Hsu, Allen L.; Borgnia, Mario J.; Haynes, Barton F.; Acharya, Priyamvada
title: Controlling the SARS-CoV-2 spike glycoprotein conformation
date: 2020-07-22
journal: Nat Struct Mol Biol
DOI: 10.1038/s41594-020-0479-4
sha: 15ea003a1d7db7de2646ba9a58c6deed06d90807
doc_id: 806692
cord_uid: urpl38qw

The coronavirus (CoV) spike (S) protein, involved in viral–host cell fusion, is the primary immunogenic target for virus neutralization and the current focus of many vaccine design efforts. The highly flexible S-protein, with its mobile domains, presents a moving target to the immune system. Here, to better understand S-protein mobility, we implemented a structure-based vector analysis of available β-CoV S-protein structures. Despite overall similarity in domain organization, we found that S-proteins from different β-CoV display distinct configurations. Based on this analysis, we developed two soluble ectodomain constructs for SARS-CoV-2 S-protein in which the highly immunogenic and mobile receptor binding domain (RBD) is either locked in the all-RBDs ‘down’ position or adopts ‘up’ state conformations more readily than wild-type S-protein. These results demonstrate that the conformation of the S-protein can be controlled via rational design and provide a framework for the development of engineered coronavirus spike proteins for vaccine applications.

The ongoing global pandemic of the novel SARS-CoV-2 coronavirus presents an urgent need for the development of effective preventative and treatment therapies. The viral S protein is a prime target for such therapies owing to its critical role in the virus lifecycle. The transmembrane CoV S-protein spike trimer is composed of interwoven protomers that include an N-terminal receptor binding S1 subunit and a C-terminal S2 subunit that contains the fusion elements ( Figure 1A and B). 1 The S1 subunit is subdivided into the N-terminal domain (NTD) followed by the receptor binding domain (RBD) and two structurally conserved subdomains (SD1 and SD2). Together these domains cap the S2 subunit, protecting the conserved fusion machinery. Binding to host receptor via the RBD in S1 is followed by proteolytic cleavage of the spike by host proteases 2 . Large conformational changes in the S-protein result in S1 shedding and exposure of the fusion machinery in S2. Class I fusion proteins, such as the CoV-2 S-protein, undergo large conformational changes during the fusion process and must, by necessity, be highly flexible and dynamic. Indeed, cryo-electron microscopy (cryo-EM) structures of SARS-CoV-2 spike reveal considerable flexibility and dynamics in the S1 subunit 1,2 , especially around the RBD that exhibits two discrete conformational states -a 'down' state that is shielded from receptor binding, and an 'up' state that is receptor-accessible.

The wealth of structural information for β-CoV spike proteins, including the recently determined cryo-EM structures of the SARS-CoV-2 spike 1-11 , has provided a rich source of detailed geometric information from which to begin precise examination of the macromolecular transitions underlying triggering of this fusion machine. Several structures of soluble ectodomain constructs that retain the complete S1 subunit and the surface exposed S2 subunit have been determined. These include SARS-CoV-2 1,3 , SARS 4-8 , MERS 4, 9 , and other human 1,10 and murine 11 β-CoV spike proteins. These structures revealed remarkable conformational heterogeneity in the S-protein spikes, especially in the RBD region. Within a single protomer, the RBD could adopt a closed 'down' state in which the RBD covers the apical region of the S2 protein near the C-terminus of the first heptad repeat (HR1), or an open 'up' state in which the RBD is dissociated from the apical central axis of S2 and the NTD ( Figure 1A) . Further, the cryo-EM structures strongly suggested a large degree of domain flexibility in both the 'down' and 'up' states in the NTD and RBD. While these structures have provided essential information to identify the relative arrangement of these domains, the degree to which conformational heterogeneity may be altered via mutation during the natural evolution of the virus and in a vaccine immunogen design context remains to be determined.

In this study we have quantified the variability in the S1 and S2 geometric arrangements to reveal important regions of flexibility to consider and to target for structure-based immunogen design. Based on these analyses, we have designed mutations that alter the conformational distribution of the domains in the S-protein. We visualized the effect of our designs using a structural determination pipeline relying first on single particle analysis by negative stain electron microscopy (NSEM) for rapid and low-cost assessment of the spike ectodomains at low resolution, followed by cryo-EM for high-resolution information on the changes introduced by these mutations. Our results reveal a heterogeneous conformational landscape of the SARS-CoV-2 spike that is highly susceptible to modification by the introduction of mutations at sites of contact between the S1 and S2 subunits. We also present data on modified SARS-CoV-2 ectodomain constructs stabilized in conformations that have not yet been seen in the current available structures, with great interest and direct application in vaccine design.

Defining domain geometry and arrangements in SARS-CoV-2 spike.

To characterize the unique arrangement of distinct domains in the different β-CoV spikes, we first developed a quantitative definition of their relative positions ( Figure 1 ). Examination of available SARS and MERS S-protein structures revealed: 1) domains in the S1 subunit (NTD, RBD, and subdomains) and in the S2 subunit (connector domain, or CD) move as rigid bodies, and 2) these domains display a pronounced array of relative shifts between those in the S1 subunit and the S2 subunit β-sheet motif and CD. In order to quantify these movements, we analyzed the relevant regions of motion and their structural disposition in available β-CoV ectodomain spike structures, including 15 for SARS 4,5,7,8 , 16 for MERS 4, 8, 12, 13 , one each for HKU1 1,10 , OC43 1,10 and a murine β-CoV; and three SARS-CoV-2 14,15 structures (Figures 1E-J and Extended Data Figure 1 ). Each protomer in these structures displaying asymmetric 'up'/down' RBD states was examined independently, yielding a dataset of 83 structural states. Structures lacking the RBD were not analyzed. Only the S1 subunits were analyzed for the HKU1, OC43 and murine β-CoV S-protein structures. Information regarding whether the constructs are cleaved, mutated, and/or liganded is provided in Supplementary Table 1. The NTD was split into a primary N-terminal section and a secondary C-terminal section based upon visual inspection of this region in the various β-CoV structures. Vectors connecting each region's C α centroids were generated and used to define the relative dispositions of the domains ( Figures 1B-C) . The vector magnitudes and select angles and dihedrals were used to identify the breadth of differences in domain positioning and compare between β-CoV viruses ( Figure 1E -J). Projecting the S1 and S2 subunit vector data for SARS-CoV-1, MERS, and SARS-CoV-2 using the principal components analysis method revealed each virus's S-protein structures resided in distinct clusters ( Figure 1E) . A similar analysis of the S1 subunit vectors with the addition of data from the murine β-CoV, HKU1, and OC43 generally retained these clusters, with the three additional structures lying in relatively unique positions ( Figure 1F ). SARS-CoV-1 structures split into two distinct clusters, separated largely by differences in the 'up'/'down' states with SARS-CoV-2 structures splitting with it. The distinct clustering of SARS-CoV-1 compared to SARS-CoV-2 in the PCA results which include the S2 subunit data suggests that there are key differences in the S1 disposition relative to S2 between SARS-CoV-1 and SARS-CoV-2.

Consistent with the PCA analysis, examination of specific angles and dihedrals indicated that β-CoV spike proteins in various viruses differ markedly from one another ( Figure 1G -J). This is in addition to considerable variability in the domain arrangements within different virus S-proteins, demonstrating its wide structural lability ( Figures 1E-J) . In particular, both ϕ 1 and ϕ 3 ( Figure 1H and J), describing the dihedrals about the vector connecting SD2 to SD1 and the vector connecting SD1 to the RBD ( Figure 1B and C) , respectively, effectively reported on the 'up' and 'down' configurations and indicated substantial differences between SARS-CoV-1 and MERS in both the 'up' and 'down' states. Differences in the angular disposition of the NTD elements of SARS-CoV-1 and MERS as measured by ϕ 1 , θ 2 and θ 4 were also observed ( Figure 1I and Extended Data Figure 1A and C). Additional S1 and S1/S2 subunit differences between viruses were observed for vectors involving SD2. This includes the SD2 to CD ϕ 4 dihedral which differs markedly between MERS/SARS-CoV-2 and SARS-CoV-1, and the angle between the vectors connecting the NTD' to SD2 and SD2 to the CD demonstrating a shift in SARS-CoV-2 (Extended Data Figure 1E and G). Finally, the disposition of the CD to the inner portion of S2 measured as an angle between a vector connected to an interior S2 β-sheet motif and the vector connecting the CD to SD2 indicates SARS-CoV-1 differs from both MERS and SARS-CoV-2 (Extended Data Figure 1F ). The MERS disposition appears to respond to RBD triggering in some structures, displaying a bimodal distribution (Extended Data Figure 1F ).

These results demonstrate that, while the individual domain architectures and overall arrangements are conserved, important differences between these domains exists between viruses, suggesting that subtle differences in inter-domain contacts could play a major role in determining these distributions and thereby alter surface antigenicity and the propensity of the domains to access 'up' and 'down' RBD states.

Based on the observed variability in the analysis of β-CoV spikes, we asked whether the propensity for the RBD to display the 'down' and 'up' states could be modified via mutations, without altering exposed antigenic surfaces. We focused on domain pairs that moved relative to each other ( Figure 1 ) and identified interaction sites that could alter the S-protein conformational distribution. That is, modification of the 'up'/'down' equilibrium could be achieved by modifying either RBD or subdomain contact surfaces. To this end, we selected contact regions between the RBD and S2, the RBD and NTD, SD1 and S2, and SD2 and S2. Mutations at these sites were selected based upon in silico mutagenesis using the Schrödinger Biologics suite 16, 17, 18 . To eliminate exposure of the receptor binding site of the RBD, we examined the potential for disulfide linkages between the RBD and its contact with S2 near the C-terminus of HR1 to prevent RBD exposure.

We identified a double cysteine mutant, S383C D985C (RBD to S2 double mutant; rS2d; Extended Data Figure 2) , as a candidate. The transition from the 'down' state to the 'up' state involves shifts in the RBD to NTD contacts. Therefore, to prevent these shifts, we identified a site in an RBD groove adjacent to the NTD, and prepared a triple mutant, D398L S514L E516L (RBD to NTD triple mutant; rNt, Extended Data Figure 2 ). As SD1 acts as a hinge point for the RBD 'up'/'down' transitions (Figures 1A-C, 2I-J), we hypothesized that enhanced hydrophobicity at the SD1 to S2 interface might shift the position of SD1, thus influencing the hinge and potentially the propensity for RBD triggering. A double mutant, N866I A570L (Subdomain 1 to S2 double mutant; u1S2d), and a quadruple mutant, A570L T572I F855Y N856I (Subdomain 1 to S2 quadruple mutant; u1S2q), were identified for this purpose (Extended Data Figure 2 ). Finally, we identified a double cysteine mutant, G669C and T866C, to link SD2 to S2 (Subdomain 1 to S2 double mutant; u2S2d, Extended Data Figure 2 ).

The mutants were prepared in the context of a previously published SARS-CoV-2 ectodomain construct 3 (Extended Data Figure 3 ). To assess the quality of the purified proteins, we performed NSEM analysis (Extended Data Figure 4) . The micrographs showed a reasonably uniform distribution of particles consistent with the size and shape of the SARS-CoV-2 spike ectodomain. 2D class averages showed spike populations with well resolved domain features.

Upon 3D-classification followed by homogeneous refinement, the unmutated spike resolved into two classes of roughly equal proportions that differed in the position of their RBD domains. One class displayed all three RBDs in their 'down' positions, whereas the other class displayed one RBD in the 'up' position. This was consistent with published cryo-EM results 19 that described a 1:1 ratio between the 'down' and '1-up' states of the SARS-CoV-2 spike ectodomain.

The mutant spikes, analyzed using a similar workflow, showed different conformation distributions compared to the unmutated spike. The most pronounced changes were observed in the rS2d and u1S2q constructs (Extended Data Figure 4C and E). For the rS2d construct, we observed only the 'down' conformation (Extended Data Figure 4C ); the 1-RBD 'up' state was not found in this dataset. In the u1S2q data, we observed an S-protein population with 2 RBDs in the 'up' position which has been reported before for the SARS-CoV-1 and MERS CoV spike ectodomains 7,12 . These two constructs were selected for downstream, high-resolution characterization by cryo-EM.

We collected cryo-EM datasets for the rS2d and u1S2q constructs (Figures 2-6, Table  1 , Extended Data . Consistent with the NSEM analysis, following multiple rounds of 2D and 3D classification, we found a population of 'down' state spike in the rS2d dataset ( Figure 3 and Extended Data Figure 6 ). We then implemented additional exhaustive ab initio classifications, as well as heterogeneous classifications using low-pass filtered maps of known open conformations of CoV spikes to search for open state spikes in the dataset. We were unable to find any such states, suggesting that the disulfide bond between the RBD and the S2 subunit effectively locked the SARS-CoV-2 spike in its 'down' conformation. The rS2d cryo-EM reconstruction had an overall resolution of 2.7 Å, but the local resolution varied widely (Extended Data Figure 6G ), with the highest resolutions in the S2 subunit (Extended Data Figure 6H ) and higher disorder and lower local resolutions in the S1 subunit; this is consistent with previous structures of the SARS-CoV-2 spike 3,14 . We observed connecting density at the site of the engineered disulfide link in rS2d, thus confirming disulfide formation ( Figure 3C -E). Alignment of this structure with that of the unmutated 'down' closed state structure (PDB 6VXX) 14 indicated that the overall protein structure was otherwise unperturbed (RMSD 0.5 Å).

We next tested binding of rS2d to antibody CR3022 ( Figure 3F and Extended Data Figure  7A ) 20, 21 . CR3022 binds an epitope on the RBD of the SARS-CoV-1 and SARS-CoV-2 spikes that is occluded in the 'down' RBD conformation. While we observed robust binding for the unmutated spike to CR3022, no measurable binding was observed for rS2d, confirming that the RBD in the rS2d construct is locked in a 'down' conformation. Also as expected, the rS2d mutant showed reduced binding to ACE-2 compared to the unmutated spike (Extended Data Figure 7B and C), and such activity could be abrogated using an ACE-2-or a CR3022 IgG-immobilized column for purification (Extended Data Figure 7C -H).

In contrast to rS2d, the u1S2q spike displayed widespread rearrangement of the S1 subunits ( Figures Extended Data Figures 8 and 9 ). In the 'down' state structure, the mutated S2 position remained in the configuration observed in the unmutated construct, with the F855Y and N856I residue loop in close proximity the S2 residue L966 and S1 residue P589 ( Figure 4C and D), suggesting these mutations had little impact on the observed shifts. However, the S2-interactive SD1 displayed a rigid body movement relative to both the rS2d and unmutated constructs with θ 1 and ϕ 3 displacements of 3.7° and 2.4°, respectively ( Figure 4E -J, Extended Data Figure 10 ). This resulted in displacement of the A570L+T572I containing loop from the unmutated position near the S2 L966 residue ( Figure 4I -J). The S2 contact disruption is accompanied by an angular shift of the NTD away from the primary trimer axis owing to SD1 to NTD' contacts, yielding θ 3 and ϕ 2 shifts of 6.0° each, respectively (Extended Data Figure 10 ). The subdomain rearrangement impacts the positioning of the RBD with only a minor shift in the ϕ 1 dihedral of 0.1° indicating the RBD moved with SD1 indicated in the θ 1 /ϕ 3 shifts. The newly acquired arrangement in both the RBD and NTD was further accompanied by an apparent increase in their flexibility suggesting conformational heterogeneity. These 'down' state shifts were observed in both the single RBD 'up' structure and the two RBD 'up' structures ( Figures 5 and 6 , Extended Data Figure 10 ). The extent to which the SD1 shift differed from that observed in the unmutated construct was context dependent in the 1 RBD 'up' state ( Figure 5C -H). While the 'down' state RBD in contact with the 'up' state RBD displayed the large shift in position observed in the all 'down' state ( Figure 5D and G), the 'down' state RBD with its terminal position free displayed an intermediate SD1 configuration (Figure 5E and H). The 'up' state RBD in the u1S2q construct resided largely in the position occupied in the unmutated construct ( Figure 5C and F). This indicated the effect of the mutations was primarily isolated to the 'down' state and suggested these mutations act to destabilize the 'down' state rather than to stabilize the 'up' state. These features were largely recapitulated in the u1S2q 2 RBD 'up' state conformation with subdomain 1 retaining the shift in the down state RBD (Supplementary Table 1 ). The structural details presented here indicate that, while locking the 'down' state RBD into its unmutated position had little impact on the overall configuration of S1, altering the disposition of SD1 had wide ranging impacts, consistent with the observed virus-to-virus differences in the geometric analysis described in Figure 1 .

We measured the binding of u1S2q with antibody CR3022 and ACE-2 ( Figure 6C and Extended Data Figure 7A -C). We observed a modest but reproducible increase in ACE-2 binding for u1S2q compared to the unmutated spike, consistent with the higher propensity of u1S2q to adopt RBD-up conformations (Extended Data Figure 7B and C). The affinities of the CR3022 antibody to the unmutated spike or u1S2q were similar, and also consistent with previously published affinity of CR3022 for an RBD-only construct 20 (Figure 6c ). Upon docking of the crystal structure of the CR3022 Fab in complex with the RBD (PDB 6YLA) 20 onto the "1-up" and "2-up" structures of u1S2q, we found that the CR3022 constant domain clashed with the NTD and the adjacent RBD in both the "1 up" conformation and the "2-up" conformations (Figure 6d,e) . As previously suggested 20 , CR3022 binding is therefore likely to require a conformational change that rotates the RBD away from the central axis of the spike. In summary, none of the structures of the structural states of the spike determined thus far are compatible with CR3022 binding and our data show that CR3022 must induce or capture this potentially transient state in both the unmutated and the u1S2q spikes.

Conformational plasticity is a hallmark of enveloped-virus fusion-protein structure, owing to the necessity of protecting the conserved viral fusion elements from host immune responses while retaining a sufficiently steep free-energy gradient to enable host cell fusion 22 . Exposed elements are generally well conditioned to be permissive and responsive to mutations through genetic drift and host immune adaptation. Conformational plasticity, however, presents an important difficulty in the context of vaccine and drug design. Indeed, lessons learned in the continued effort to produce a broadly protective HIV-1 vaccine have demonstrated the importance of a detailed understanding and control of fusion protein dynamics [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] . SARS-CoV-2 is likely no exception in this regard and, indeed, the conformational plasticity of the SARS-CoV-2 S-protein appears greater than that of the HIV-1 Env.

We aimed to develop a quantitative understanding of β-CoV structural states between viruses and within each RBD 'down' and 'up' state configuration. The wide breadth of domain arrangements and the relatively small contact area between the S1 and S2 subunits suggest that large changes in S-protein structure may occur from few mutations. A recent report indicated that the D614G mutation (located in the SD2 region and contacting S2) causes a potential fitness gain 35 . Based on our results showing that a disulfide linkage between SD2 and S2 in u2S2d decreased the population of 'up' state RBDs (Extended Data Figure 4B ), the D614G mutation may indeed alter the conformational landscape of the SARS-CoV-2 S-protein. It was previously noted that the RBD up states observed in MERS and SARS-CoV-1 were not observed in the OC43, MHV, or HKU1 S-protein structures 10 . We note that the SD1 u1S2q mutation sites are all asparagine in those other CoV S-proteins and each displays a marked difference in SD1 positioning relative to the u1S2q structure. Thus, sequence differences at interdomain contact sites are not uncommon, and our observations suggest that the β-coronaviruses can quickly evade conformationally selective antibody responses. However, the degree to which this evasion mechanism is effectively utilized by the virus is uncertain, as such mutations may simultaneously incur a fitness penalty.

From the perspective of immunogen development, the constructs developed here present an opportunity to examine the ability of differentially stabilized S-protein particles to induce two different, yet important antibody responses. First, the u1S2q construct developed here displayed a prominent two RBD 'up' state distribution, demonstrating that interdomain contact modifications can lead to higher exposure of the immunogenic receptor binding regions. Since RBD-directed responses that target the ACE-2 binding site form a dominant proportion of neutralizing immune responses in infected patients 36 , constructs that increase exposure and access to these sites could be useful candidates for vaccination regimens aimed at eliciting such responses. Indeed, full-length SARS-CoV-2 spike structures, either detergent solubilized 37 or virion associated 38 , suggest the 'down' state is the predominant state which, in a vaccination context, may limit RBD-directed responses. The u1S2q mutations may therefore provide a means to enhance the induction of RBD responses in full-length S-protein immunogens. Furthermore, this design could also be used to identify receptor binding site-directed antibodies from patient sera, including potential new antibodies that may target sites that require a two RBD 'up' conformation. Second, the disulfide-linked 'down' state locked double mutant (rS2d) would presumably not elicit antibodies targeting the receptor binding site, which make up the majority of observed responses in convalescent patients 39, 40 , but it would still be capable of eliciting antibodies such as S309 that are able to bind the 'down' state RBD 41 . Indeed, a study of MERS responses suggests non-RBD responses (particularly NTD and S2 epitopes) will play an important role in vaccine induced protection 42 . From a theoretical perspective, the wide control over the RBD 'up'/'down' distribution available to the virus suggests that, by analogy to HIV-1 viruses, which are notoriously difficult to neutralize, conformational blocking of antibody responses would not be unusual. While there might be a fitness cost to the virus, it would not necessarily render the virion non-infectious. Using the double mutant rS2d as an immunogen provides a platform for inducing non-RBD responses that may be needed to protect against such an evasion. While the low expression yields of rS2d are a potential hindrance to its utility, introduction of other mutations, such as the recently described mutations designed to stabilize the S2 region 43 may provide a way to further stabilize rS2d and increase its utility as an immunogen.

Complicating factors, such as a potential for antibody-induced enhancement, may favor the use of truncated, single-domain constructs with fewer potentially weak or non-neutralizing epitopes. Nevertheless, the designs presented here will allow for a detailed characterization of vaccine immunogenicity and antigenicity, paving the way for the development of vaccines for the novel SARS-CoV-2 and eventually a broadly protective β-CoV vaccine. Thus, while the previous generation of stabilizing mutations ensured well folded spike trimers, the rational design approach developed here provides a means to controlling the RBD orientation distribution, and should allow us to explore the impact of conformational dynamics from the perspective of vaccine and drug development.

Vector analysis was performed using available cryo-EM structures for SARS-CoV-2 14,15 , SARS 4,5,7,8 , MERS 4, 12 , and other human 1,10 and murine 11 β-CoV spike proteins. Domains for the vector analysis were selected based upon visual inspection of alignments between SARS, MERS, and SARS-CoV-2 structures. Specifically, C α centroids for the S1 NTD, RBD, SD1, SD2 (SARS-CoV-2 residues, 27-43 and 54-271, 330-443 and 503-528, 323-329 and 529-590, 294-322 and 591-696, respectively; equivalent SARS/MERS/Murine/ HKU1/OC43 residues selected based upon structural alignment with SARS-CoV-2) as well as a β-sheet motif in the NTD (residues 116 −129 and 169-172) and a helix motif in the RBD (residues 403-410) were determined. The NTD was split into two regions with the SD1 contacting, SD2 adjacent portion referred to here as the NTD' (residues 44-53 and 272-293). C α centroids in the S2 subunit were obtained for a β-sheet motif (residues 717-727 and 1047-1071) and the CD domain (711-716 and 1072-1122). Vector magnitudes, angles, and dihedrals between these centroids were determined and used in the subsequent analysis. Vector analysis was performed using the VMD 44 Tcl interface. Principal component analysis performed in R with the vector data centered and scaled 45 .

Structures for SARS-COV-1 (PDB 5X58 4 ), MERS (PDB 6Q04 13 ), and SARS-CoV-2 (PDB 6VXX 19 ) were prepared in Maestro 46 using the protein preparation wizard 16 followed by in silico mutagenesis using Schrödinger's cysteine mutation 17 and residue scanning 18 tools.

Residue scanning was first performed for individual selected sites allowing mutations to Leu, Ile, Trp, Tyr, and Val followed by scanning of combinations for those which yielded a negative overall score. Scores and visual inspection were used in the selection of the prepared constructs.

The SARS-CoV-2 ectodomain constructs were produced and purified as described previously 3 . Briefly, a gene encoding residues 1-1208 of the SARS-CoV-2 S (GenBank: MN908947) with proline substitutions at residues 986 and 987, a "GSAS" substitution at the furin cleavage site (residues 682-685), a C-terminal T4 fibritin trimerization motif, an HRV3C protease cleavage site, a TwinStrepTag and an 8XHisTag was synthesized and cloned into the mammalian expression vector pαH. All mutants were introduced in this background. Expression plasmids encoding the ectodomain sequence were used to transiently transfect FreeStyle293F cells using Turbo293 (SpeedBiosystems). Protein was purified on the sixth day post-transfection from the filtered supernatant using StrepTactin resin (IBA).

Antibody CR3022 was produced in Expi293 cells and purified by Protein A affinity. For expressing the ACE-2 constructs, the ACE-2 gene was cloned as a fusion protein with either the human or mouse Fc region attached to the C-terminal end of ACE-2. A 6X His-tag was added to the C-terminal end of the Fc domain of each construct. ACE-2 with human Fc tag was purified by Protein A affinity chromatography, and ACE-2 with mouse FC tag was purified by Ni-NTA chromatography.

The thermal shift assay was performed using Tycho NT. 6 (NanoTemper Technologies). Spike variants were diluted (0.15 mg/ml) in nCoV buffer (2mM Tris, pH 8.0, 200 mM NaCl, 0.02% sodium azide) and run in duplicates in capillary tubes. Intrinsic fluorescence was recorded at 330 nm and 350 nm while heating the sample from 35-95 °C at a rate of 3 °C/min. The ratio of fluorescence (350/330 nm) and the Ti were calculated by Tycho NT. 6.

A 100 μg/ml final concentration of the spike was made in 1:1 ratio of 0.15% glutaraldehyde in HBS pH 7.4 (20mM HEPES, 150mM NaCl) to 10% Glycerol in HBS pH 7.4. After 5 min incubation Tris pH 7.4 was added from a 1M stock to a final concentration of 0.075M to quench the glutaraldehyde and incubated for 5min. The carbon coated grids (CF300-cu, EMS) were glow discharged for 20sec at 15mA. A 5 μl of sample incubated on grid for 10-15 sec, blotted and then stained with 2% uranyl formate. Images were obtained with a Philips EM420 electron microscope operated at 120 kV, at 82,000× magnification and a 4.02 Å pixel size. The RELION 47 program was used to perform class averaging of the single-particle images

Purified SARS-CoV-2 spike preparations were diluted to a concentration of ~1 mg/mL in 2 mM Tris pH 8.0, 200 mM NaCl and 0.02% NaN3. 2.5 μL of protein was deposited on a CF-1.2/1.3 grid that had been glow discharged for 30 seconds in a PELCO easiGlow ™ Glow Discharge Cleaning System. After a 30 s incubation in >95% humidity, excess protein was blotted away for 2.5 seconds before being plunge frozen into liquid ethane using a Leica EM GP2 plunge freezer (Leica Microsystems). Frozen grids were imaged in a Titan Krios (Thermo Fisher) equipped with a K3 detector (Gatan). Data were acquired using the Leginon system 48 . The dose was fractionated over 50 raw frames and collected at 50ms framerate. This dataset was energy-filtered with a slit width of 30 eV. Individual frames were aligned and dose-weighted 49 . CTF estimation, particle picking, 2D classifications, ab initio model generation, heterogeneous refinements, homogeneous 3D refinements and local resolution calculations were carried out in cryoSPARC 50 .

Structures of the all 'down' state (PDB 6VXX) and single RBD 'up' state (PDB 6VYB) from the previously published SARS-CoV-2 ectodomain were used to fit the cryo-EM maps in Chimera 51 . The 2 RBD 'up' state was generated in PyMol using the single RBD 'up' state structure. Mutations were made in PyMol 52 . Coordinates were then fit manually in Coot 53 followed by iterative refinement using Phenix 54 real space refinement and subsequent manual coordinate fitting in Coot. Structure and map analysis were performed using PyMol, Chimera 51 and ChimeraX 55 .

The binding of antibody CR3022 and ACE-2 to the SARS-CoV-2 spike constructs was assessed by surface plasmon resonance on Biacore T-200 (GE-Healthcare) at 25°C with HBS-EP+ (10 mM HEPES, pH 7.4, 150 mM NaCl, 3 mM EDTA, and 0.05% surfactant P-20) as the running buffer. The spike constructs were captured on SA chip and were assayed by flowing over CR3022 IgG or ACE-2-Fc. The surface was regenerated between injections by flowing over SA regeneration buffer (1M NaCl, 50mM NaOH) solution for 10s with flow rate of 100μl/min. Blank sensorgrams were obtained by injection of the same volume of HBS-EP+ buffer in place of IgGs and Fab solutions. Sensorgrams were corrected with corresponding blank curves. For testing in the reverse format, CR3022 IgG or ACE2-humanFc was immobilized on captured on CM5 chip immobilized with human Anti-Fc (8000RU) were assayed by nCoV spike at 200nM in running buffer. The surface was regenerated between injections by flowing over 3M MgCl2 solution for 10s with flow rate of 100μl/min. For assessing the affinity of CR3022 to the unmutated and u1S2q spikes, the spikes were captured on an SA chip as described above, and 5 concentrations of CR3022 were injected in a single cycle kinetics format. Sensorgram data were analyzed using the BiaEvaluation software (GE Healthcare).

Further information on experimental design is available in the Nature Research Reporting Summary linked to this article. 

Cryo-EM reconstructions and atomic models were deposited in the EMDB and wwPDB with accession codes EMD-21997, EMD-21999, EMD-22000 and EMD-22001, and PDB 6X29, 6X2A, 6X2B and 6X2C. Source data for graphs are available in Supplementary Data 1. A) The S-protein spike highlighting the two regions of interest for structure and computation-based design (PDB 6VXX). B) The rS2d RBD to S2 locked structure displaying only the all RBD 'down' state map. C) The u1S2q SD1-to-S2 mutated structure displaying the all RBD 'down' state, the 1-RBD 'up' state, and the 2-RBD 'up' state. The percentage listed in orange is the sum of particles found in either 1-or 2-RBD 'up' states. Each protomer in each map is colored differently with resolutions for these listed to the lower left. Red stars indicate 'up' state RBDs. Cryo-EM reconstruction of u1S2q 1 RBD "up" state colored by chain. B) ~90 rotated view of (A). C-E) Zoomed-in views of the region containing the A570L and T572I mutations in each of the protomers of the asymmetric 1-RBD "up" spike. The cryo-EM reconstruction is shown as a transparent surface with the underlying fitted model in cartoon representation and residues as balls and sticks. (F-H) The 1-RBD "up" structure of the unmutated spike (PDB 6VYB) (shown in black and grey) superimposed on the u1S2q 1-RBD "up" structure (PDB 6X2B, this study), colored according to the coloring scheme in (A). A) Cryo-EM reconstruction of u1S2q colored by chain. B) ~90 rotated view of (A). C) Binding of antibody CR3022 to (top) the unmutated construct and (bottom) u1s2q. Binding of CR3022 Fab to the S proteins was measured by SPR using single cycle kinetics. The black lines are the binding sensorgrams and the red lines show fit of the data to a 1:1 Langmuir binding model. (D) CR3022 (shown as a semi-transparent, gray surface) modeled on the "1-up" u1S2q structure (left) and the "2-up" u1S2q structure (right) using RBD in the crystal structure of the CR3022-RBD complex (PDB 6W41) to superimpose on the "up" RBD of the u1S2q structures. Locations of potential clashes are indicated in each model. Table 1 Cryo-EM data collection, refinement and validation statistics 

Pre-fusion structure of a human coronavirus spike protein

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains

Cryo-electron microscopy structures of the SARS-CoV spike glycoprotein reveal a prerequisite conformational state for receptor binding

EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2

Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis

Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion

Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen

Structural basis for human coronavirus attachment to sialic acid receptors

Cryo-electron microscopy structure of a coronavirus spike glycoprotein trimer

Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen

Structures of MERS-CoV spike glycoprotein in complex with sialoside attachment receptors

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments

Pearlman DA Structure-based approach to the prediction of disulfide bonds in proteins

Loving KA Applying Physics-Based Scoring to Calculate Free Energies of Binding for Single Amino Acid Mutations in Protein Protein Complexes

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV

Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants

Common Features of Enveloped Viruses and Implications for Immunogen Design for Next-Generation Vaccines

Immunogenicity of Stabilized HIV-1 Envelope Trimers with Reduced Exposure of Non-neutralizing Epitopes

HIV-1 vaccine design through minimizing envelope metastability

Interdomain Stabilization Impairs CD4 Binding and Improves Immunogenicity of the HIV-1 Envelope Trimer

Structure-Based Design of a Soluble Prefusion-Closed HIV-1 Env Trimer with Reduced CD4 Affinity and Improved Immunogenicity

Improving the Immunogenicity of Native-like HIV-1 Envelope Trimers by Hyperstabilization

Design and crystal structure of a native-like HIV-1 envelope trimer that engages multiple broadly neutralizing antibody precursors in vivo

HIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing Antibodies

Structure-based design of native-like HIV-1 envelope trimers to silence non neutralizing epitopes and eliminate CD4 binding

Structure-Guided Redesign Improves NFL HIV Env Trimer Integrity and Identifies an Inter-Protomer Disulfide Permitting Post-Expression Cleavage

Cleavage-independent HIV-1 Env trimers engineered as soluble native spike mimetics for vaccine design

Structure-Guided Redesign Increases the Propensity of HIV Env To Generate Highly Stable Soluble Trimers

Structure and immunogenicity of a stabilized HIV-1 envelope trimer based on a group-M consensus sequence

Spike mutation pipeline reveals the emergence of a more transmissible form of SARS-CoV-2. bioRxiv

Structures of human antibodies bound to SARS-CoV-2 spike reveal common epitopes and recurrent features of antibodies

Distinct conformational states of SARS-CoV-2 spike protein. bioRxiv

In situ structural analysis of SARS-CoV-2 spike reveals flexibility mediated by three hinges. bioRxiv

Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein. bioRxiv

Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability. bioRxiv

Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody

Importance of Neutralizing Monoclonal Antibodies Targeting Multiple Antigenic Sites on the Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein To Avoid Neutralization Escape

Structure-based Design of Prefusion-stabilized SARS-CoV-2 Spikes. bioRxiv

Visual molecular dynamics

R: A Language and Environment for Statistical Computing

Schrödinger Release 2020-1: Maestro (Schrödinger, LLC

Automated molecular microscopy: the new Leginon system

MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy

algorithms for rapid unsupervised cryo-EM structure determination

UCSF Chimera-A visualization system for exploratory research and analysis

Schrodinger L The PyMOL Molecular Graphics System

Real-space refinement in PHENIX for cryo-EM and crystallography

Meeting modern challenges in visualization and analysis

The OC43 value of −162° was adjusted to 197 °(+360 °) for visualization here. J) Dihedral about the SD2-to-SD1 vector. Data points for SARS, MERS, and SARS-2 in g-j colored according to 'up' (dark) and 'down' (light) states and color code in the PCA analysis in panels e and f. Lines show mean and s.d. The PDB IDs for all structures represented in the PCA and angle/dihedral plots are listed in Supplementary Table 1. K) Structural representation of the (G)-(J) angles and dihedrals overlaid on an alignment between a SARS-2 'down' (cartoon structure with black centroids and lines

Adjacent protomers are depicted as a transparent surface with S1 (light blue) and S2 (light pink). Source data for graphs here are in Supplementary Data 1

Initial cryo-EM data were collected on the Titan Krios at the Shared Materials and Instrumentation Facility in Duke University. Data collection for high-resolution structure determination was performed at the National Center for Cryo-EM Access and Training (NCCAT) and the Simons Electron Microscopy Center located at the New York Structural Biology Center, supported by the NIH Common Fund Transformative High Resolution Cryo-Electron Microscopy program (U24 GM129539) and by grants from the Simons Foundation (SF349247) and NY State. We thank Ed Eng, Daija Bobe, Mark Walters and Holly Leddy for microscope alignments and assistance with cryo-EM